BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38123137)

  • 21. Thrombopoietin mimetics for patients with myelodysplastic syndromes.
    Dodillet H; Kreuzer KA; Monsef I; Skoetz N
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009883. PubMed ID: 28962071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet utilization and the transfusion trigger: a prospective analysis.
    Greeno E; McCullough J; Weisdorf D
    Transfusion; 2007 Feb; 47(2):201-5. PubMed ID: 17302764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.
    Oliva EN; Alati C; Santini V; Poloni A; Molteni A; Niscola P; Salvi F; Sanpaolo G; Balleari E; Germing U; Fenaux P; Stamatoullas A; Palumbo GA; Salutari P; Impera S; Avanzini P; Cortelezzi A; Liberati AM; Carluccio P; Buccisano F; Voso MT; Mancini S; Kulasekararaj A; Morabito F; Bocchia M; Cufari P; Spiriti MA; Santacaterina I; D'Errigo MG; Bova I; Zini G; Latagliata R
    Lancet Haematol; 2017 Mar; 4(3):e127-e136. PubMed ID: 28162984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preprocedural platelet transfusion for patients with thrombocytopenia undergoing interventional radiology procedures is not associated with reduced bleeding complications.
    Warner MA; Woodrum D; Hanson A; Schroeder DR; Wilson G; Kor DJ
    Transfusion; 2017 Apr; 57(4):890-898. PubMed ID: 28130779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New strategies for the optimal use of platelet transfusions.
    Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
    Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of thrombopoietin receptor agonist on health-related quality of life and platelet transfusion burden for patients with myelodysplastic syndromes: a systematic review and meta-analysis.
    Wang K; Shao Y; Li C; Bao J; Zhu W; Zhou Y
    Ann Hematol; 2022 Oct; 101(10):2219-2229. PubMed ID: 35976414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
    Estcourt LJ; Stanworth S; Doree C; Trivella M; Hopewell S; Blanco P; Murphy MF
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010984. PubMed ID: 26505729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchoscopy can be done safely in patients with thrombocytopenia.
    Nandagopal L; Veeraputhiran M; Jain T; Soubani AO; Schiffer CA
    Transfusion; 2016 Feb; 56(2):344-8. PubMed ID: 26446048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial.
    Gernsheimer TB; Brown SP; Triulzi DJ; Key NS; El Kassar N; Herren H; Poston JN; Boyiadzis M; Reeves BN; Selukar S; Pagano MB; Emerson S; May S
    Blood; 2022 Sep; 140(11):1254-1262. PubMed ID: 35667085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
    Stanworth SJ; Dyer C; Choo L; Bakrania L; Copplestone A; Llewelyn C; Norfolk D; Powter G; Littlewood T; Wood EM; Murphy MF;
    Transfus Med Rev; 2010 Jul; 24(3):163-71. PubMed ID: 20656185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia.
    Zeidler K; Arn K; Senn O; Schanz U; Stussi G
    Transfusion; 2011 Nov; 51(11):2269-76. PubMed ID: 21517892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study.
    Stanworth SJ; Walsh TS; Prescott RJ; Lee RJ; Watson DM; Wyncoll DL;
    Transfusion; 2013 May; 53(5):1050-8. PubMed ID: 22928908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia.
    Giagounidis A; Mufti GJ; Fenaux P; Sekeres MA; Szer J; Platzbecker U; Kuendgen A; Gaidano G; Wiktor-Jedrzejczak W; Hu K; Woodard P; Yang AS; Kantarjian HM
    Cancer; 2014 Jun; 120(12):1838-46. PubMed ID: 24706489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
    Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia.
    Garcia-Manero G; Scott BL; Cogle CR; Boyd TE; Kambhampati S; Hetzer J; Dong Q; Kumar K; Ukrainskyj SM; Beach CL; Skikne BS
    Leuk Res; 2018 Sep; 72():79-85. PubMed ID: 30114559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical analysis of pregnancy complicated with severe thrombocytopenia].
    Wang DP; Liang MY; Wang SM
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):401-5. PubMed ID: 21029587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.
    Malouf R; Ashraf A; Hadjinicolaou AV; Doree C; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012342. PubMed ID: 29758592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal Platelet Transfusions and Future Areas of Research.
    Sola-Visner M; Bercovitz RS
    Transfus Med Rev; 2016 Oct; 30(4):183-8. PubMed ID: 27282660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.